Increased erythrocyte sodium-lithium countertransport is observed in patients with essential hypertension. Genomic regions influencing inter-individual variation in sodium-lithium countertransport have been identified by linkage analyses. While numerous studies of complex disease traits have carried out genome-wide linkage analyses, few have successfully used this information to identify underlying disease susceptibility genes. We propose a practical research strategy to follow-up a replicated linkage peak on chromosome 10 identified from genome-wide scans for sodium-lithium countertransport. This region contains only 55 genes in the overlap of the 1 LOD confidence intervals from each Phase of the Rochester Family Heart Study. This allows for the examination of the contribution of every gene to the primary and secondary traits of interest (i.e. sodium-lithium countertransport and hypertension, respectively). The goal of the project is the identification of allelic variation influencing sodium-lithium countertransport as well as risk of developing essential hypertension.
| Zheng, Xiaojing; Morrison, Alanna C; Feingold, Eleanor et al. (2011) Association between NEDD4L gene and sodium lithium countertransport. Am J Hypertens 24:145-8 |
| Zheng, Xiaojing; Morrison, Alanna C; Turner, Stephen T et al. (2011) Association between SLC20A1 and sodium-lithium countertransport. Am J Hypertens 24:1069-72 |
| Zheng, Xiaojing; Kammerer, Candace M; Cox, Laura A et al. (2009) Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons. Am J Hypertens 22:288-93 |
| Klos, Kathy L E; Boerwinkle, Eric; Ferrell, Robert E et al. (2008) ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study. J Lipid Res 49:1701-6 |
| Morrison, Alanna C; Boerwinkle, Eric; Turner, Stephen T et al. (2008) Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10. Am J Hypertens 21:117-21 |
